Abstract: Devices and methods for treating or repairing a tissue or organ defect or injury are provided. The devices can include tissue scaffolds produced from acellular tissue matrices and polymers, which have a stable three-dimensional shape and elicit a limited immunologic or inflammatory response.

Abstract: The present disclosure provides a variety of methods and compositions (e.g., solutions) useful for making, sterilizing, and preserving tissues (e.g., acellular tissue matrices). The disclosure also features the acellular tissue matrices made by the methods, which matrices can be used for a variety of applications such as, but not limited to, treating an injury to, or repairing, a large number of tissues and/or organs (e.g., e.g., fascia, bones, and/or cartilage) in a mammal (e.g., a human).

Abstract: Disclosed herein are tissue treatment products that have been bound to at least one chelating agent. Also disclosed are tissue treatment products that have been functionalized with at least one metal and/or at least one metal-binding protein. The tissue treatment products can have antimicrobial properties and/or factors that promote or enhance native cell migration, proliferation, and/or revascularization after implantation into a subject. Also disclosed are methods of making and using the tissue treatment products. The tissue treatment products can be implanted into a tissue in need of repair, regeneration, healing, treatment, and/or alteration and can promote or enhance native cell migration, proliferation, and/or revascularization.

Abstract: Tissue fillers derived from decellularized tissues are provided. The tissue fillers can include acellular tissue matrices that have reduced inflammatory responses when implanted in a body. Also provided are methods of making and therapeutic uses for the tissue fillers.

Abstract: This invention provides a toner with improved charge and charge stability by suitable addition of extra particulate additives (EPA) such as aluminum cerium oxide and/or cerium zirconium oxide. The additives may be combined with toner in a conical mixer having selected temperature control. The invention also provides toner which may provide reduced print quality defects such as ghosting or residual image and fade-to-color.

Abstract: Methods, mixtures, and kits related to treating tissue are provided. The methods, mixtures, and kits can include an acellular tissue matrix, a polymer, and a solvent and may be capable of producing tissue scaffolds. The tissue scaffolds may be able to form a stable, three-dimensional shape in situ and elicit a limited immunologic or inflammatory response.

Abstract: Devices and methods for treating or repairing a tissue or organ defect or injury are provided. The devices can include tissue scaffolds produced from acellular tissue matrices and polymers, which have a stable three-dimensional shape and elicit a limited immunologic or inflammatory response.

Abstract: This invention provides a toner with improved charge and charge stability by suitable addition of extra particulate additives (EPA) such as aluminum cerium oxide and/or cerium zirconium oxide. The additives may be combined with toner in a conical mixer having selected temperature control. The invention also provides toner which may provide reduced print quality defects such as ghosting or residual image and fade-to-color.

Abstract: A toner composition and method of providing such composition which may be used in a printer or printer cartridge. The composition may include toner particles mixed with silica particles having a primary particle size in the range of 30 nm to 60 nm present in the range of 0.1 to 2.0% by weight of the toner composition and silica particles having a primary particle size in the range of 60 nm to 150 nm present in the range of 0.1 to 2% by weight of the toner composition.

Abstract: A toner composition and a method of making a toner composition wherein toner particles having an average size in the range of 1-25 ?m may be mixed with silica particles and alumina particles surface treated with an inorganic/organic compound. The silica particles may have a primary particle size in the range of 2 nm to 20 nm and may be present in the range of 0.01% to 3.0% by weight of the toner composition. The alumina particles surface treated with an inorganic/organic compound may be present in the range of 0.01% to 1.0% by weight of the toner composition.

Abstract: A method for producing toner, and a toner composition, which includes polymer binder and a release agent composition that has relatively high viscosity and associated melting characteristics that improve filming resistance and/or fusing performance. The toner may be prepared by a chemical process wherein the toner particles may be grown in an aqueous solution to obtain a desired toner particle size.

Abstract: The present disclosure relates to chemically processed toner, wherein fuser release agent (wax) may be dispersed in a fluid containing a dispersant. Introduced to the wax dispersion are one or more polymerizable monomers which may be polymerized to form a latex of polymer particles. The polymer particles may then serve as a binder for the formation of toner for use in an electrophotographic printer. The polymerizable monomers may utilize acrylic esters that include relatively long chain hydrocarbon type substitution.

Abstract: The present invention relates to the combination of a chemically processed toner with extra particulate additive in a conical mixer. The toner may include polymer resins having a glass transition temperature (Tg) wherein the mixer and/or toner may be maintained below the glass transition temperature during mixing. Prior to mixing the toner particles may also be de-agglomerated or mechanically agitated.

Abstract: The present invention relates to a method for combining extra particulate additive with toner. The method includes mixing toner and extra particulate additive in a conical mixer having temperature control. The toner may contain polymeric material having a glass transition temperature (Tg) and the mixing may be carried out wherein the temperature of the mixture is maintained at a temperature less than Tg. The above method may also be applied to a toner formulation that has first undergone a rounding operation.

Abstract: A collagen-binding MSCRAMM entitled Ace from enterococcal bacteria is provided which was homologous to the ligand-binding region of Cna, the collagen-binding MSCRAMM from Staphylococcus aureus, and which can be utilized to inhibit adhesion of enterococcal bacteria to extracellular matrix proteins. The N-terminal region of Ace contained a region (residues 174-319), or A domain, contains several 47-residue tandem repeat units between the collagen-binding site and cell wall-associated regions. The Ace protein can be utilized in methods of preventing and/or treating enterococcal infection, and in addition, antibodies raised against Ace, or its A domain, can be used to effectively inhibit the adhesion of enterococcal cells to a collagen substrate.

Abstract: A safety harness having a chest strap received over a user's shoulders, a crotch strap received between a user's legs and selectively attachable to the chest strap, and a back panel received against a user's back, the back panel being interposed between the crotch strap and chest strap. The back panel is substantially the width of the user's shoulders and the height of the user's torso to evenly disperse and dissipate forces from sudden movements acted upon a user when the harness is secured to a vehicular seatbelt.

Abstract: A high speed toner comprising a body of hybrid resin which is about 92 percent by weight polyester and 8 percent by weight polystyrene. Blended in the resin is a charge control agent, a pigment, and about 10 percent by weight of the toner of fumed aluminum oxide. Where the pigments are color-subtractive the charge control agent is a copolymer of styrene and 2-acrylamido-2-methylpropane sulfonic acid.The toner is mixed with a carrier of ferrite particles having a thick silicone coating to remain through the long life of the toner.

Abstract: Method and apparatus for adjusting the position of a single-focus lens at two positions in a continuously variable reduction document copier machine. Adjustment is made at a 1:1 ratio by shifting the position of the lens on its carriage and adjusting the position of optical path mirrors until focus is obtained. Adjustment is made at a nominal 0.647 reduction ratio by adjusting the position of the lens carriage until focus is obtained. Apparatus is disclosed which provides the second adjustment without affecting the position of the lens at the first adjustment position.